Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas

Fig. 1

Molecular subgroups of medulloblastoma. The current consensus divides medulloblastoma into four subgroups: WNT-activated (WNT), SHH-activated (SHH), group 3, and group 4. Only the most frequently altered genes are listed for group 3 and group 4 (a). Adult samples are extremely rare among group 3 patients, while the majority of group 4 tumors consist of children (b)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us